IPAX-BRIGHT Trademark

Trademark Overview

On Tuesday, April 29, 2025, a trademark application was filed for IPAX-BRIGHT with the United States Patent and Trademark Office. The USPTO has given the IPAX-BRIGHT trademark a serial number of 79426083. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 19, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The IPAX-BRIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals
ipax-bright

General Information

Serial Number79426083
Word MarkIPAX-BRIGHT
Filing DateTuesday, April 29, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressAU

Trademark Events

Event DateEvent Description
Thursday, June 19, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, July 2, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 1, 2026NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

bright ipax research field pharmaceuticals testing cancer clinical medical pharmaceutical consultancy development